InBody CoLtd Valuation
| 041830 Stock | KRW 24,100 1,600 6.23% |
At this time, the firm appears to be overvalued. InBody CoLtd owns a latest Real Value of W22301.25 per share. The recent price of the firm is W24100.0. Our model calculates the value of InBody CoLtd from examining the firm fundamentals such as Operating Margin of 0.26 %, current valuation of 331.29 B, and Return On Asset of 0.12 as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that InBody CoLtd's price fluctuation is very steady at this time. Calculation of the real value of InBody CoLtd is based on 3 months time horizon. Increasing InBody CoLtd's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since InBody CoLtd is currently traded on the exchange, buyers and sellers on that exchange determine the market value of InBody Stock. However, InBody CoLtd's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 24100.0 | Real 22301.25 | Hype 24100.0 | Naive 23755.67 |
The real value of InBody Stock, also known as its intrinsic value, is the underlying worth of InBody CoLtd Company, which is reflected in its stock price. It is based on InBody CoLtd's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of InBody CoLtd's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of InBody CoLtd helps investors to forecast how InBody stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of InBody CoLtd more accurately as focusing exclusively on InBody CoLtd's fundamentals will not take into account other important factors: InBody CoLtd Total Value Analysis
InBody CoLtd is presently estimated to have takeover price of 331.29 B with market capitalization of 326.28 B, debt of 1.83 B, and cash on hands of 18.56 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the InBody CoLtd fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
331.29 B | 326.28 B | 1.83 B | 18.56 B |
InBody CoLtd Investor Information
About 29.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. InBody CoLtd had 2:1 split on the 23rd of April 2010. Based on the measurements of operating efficiency obtained from InBody CoLtd's historical financial statements, InBody CoLtd is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.InBody CoLtd Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. InBody CoLtd has an asset utilization ratio of 67.65 percent. This suggests that the Company is making W0.68 for each dollar of assets. An increasing asset utilization means that InBody CoLtd is more efficient with each dollar of assets it utilizes for everyday operations.InBody CoLtd Ownership Allocation
The market capitalization of InBody CoLtd is W326.28 Billion. InBody CoLtd shows large amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.InBody CoLtd Profitability Analysis
The company reported the revenue of 137.84 B. Net Income was 33.98 B with profit before overhead, payroll, taxes, and interest of 77.06 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates InBody CoLtd's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in InBody CoLtd and how it compares across the competition.
About InBody CoLtd Valuation
The stock valuation mechanism determines InBody CoLtd's current worth on a weekly basis. Our valuation model uses a comparative analysis of InBody CoLtd. We calculate exposure to InBody CoLtd's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of InBody CoLtd's related companies.InBody Co., Ltd. provides body composition analysis solutions worldwide. InBody Co., Ltd. was founded in 1996 and is based in Mumbai, India. InBody is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct InBody CoLtd's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates InBody CoLtd's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct InBody CoLtd's valuation analysis, follow these 8 steps:- Gather financial information: Obtain InBody CoLtd's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine InBody CoLtd's revenue streams: Identify InBody CoLtd's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research InBody CoLtd's industry and market trends, including the size of the market, growth rate, and competition.
- Establish InBody CoLtd's growth potential: Evaluate InBody CoLtd's management, business model, and growth potential.
- Determine InBody CoLtd's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate InBody CoLtd's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for InBody Stock analysis
When running InBody CoLtd's price analysis, check to measure InBody CoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InBody CoLtd is operating at the current time. Most of InBody CoLtd's value examination focuses on studying past and present price action to predict the probability of InBody CoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InBody CoLtd's price. Additionally, you may evaluate how the addition of InBody CoLtd to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |